XORTX Therapeutics Provides Update On FDA Type B Meeting Request
View all comments(0)
April 30 (Reuters) - XORTX Therapeutics Inc XRTX.V:
XORTX PROVIDES UPDATE ON FDA TYPE B MEETING REQUEST
XORTX THERAPEUTICS INC - EXPECTS TO FILE GOUT NDA IN H1 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Why SanDisk Stock Could Soar to $4,000?

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

AI Chip Sector Adds Heavyweight Player, Nvidia Rival Cerebras Plans to List Next Week, Targeting Largest US IPO of the Year

Global First Storage ETF Surges 88% Five Weeks After Listing. Is It Too Late to Buy Now?

Trump Administration Brokers. Intel and Apple Reach Chipmaking Agreement, Shares Surge More Than 13%

Tradingkey








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.